IKZF1 and acute lymphoblastic leukemia: Clinical studies found that genetic alterations in Ikaros genes correlates to a poor outcome in high-risk acute lymphoblastic leukemia (ALL) patients and it was highlighted that the 83.7% of patients with Philadelphia chromosome-carrying ALL had partially or total decrease of IKZF1 gene expression (41).